Pentorin 40mg

Description:

PAN 40 Injection is an intravenous (IV) formulation of pantoprazole used for the short-term management of severe or acute acid-related gastrointestinal disorders, particularly when oral administration is not possible (e.g., due to vomiting, surgery, or critical illness). It provides rapid acid suppression (within 1 hour) and sustained effect for up to 24 hours. The injection is supplied as a lyophilized powder in a vial, reconstituted with normal saline or dextrose for IV bolus or infusion. It is typically administered in hospital settings and transitioned to oral forms once feasible. Not for self-administration; veterinary use only under medical supervision.

Active Salt (Composition):

• Pantoprazole Sodium (40 mg per vial, equivalent to 40 mg pantoprazole base)

Pantoprazole is a proton pump inhibitor (PPI) that irreversibly blocks the final step of gastric acid production by inhibiting the H+/K+ ATPase enzyme in the parietal cells of the stomach lining. This reduces stomach acid secretion, allowing healing of acid-related damage.

Uses and Benefits:

PAN 40 Injection is indicated for conditions involving excessive gastric acid production, offering quick symptom relief and promoting mucosal healing. Key uses and benefits include:

1. Gastroesophageal Reflux Disease (GERD) or Erosive Esophagitis:

• Use: Treats severe acid reflux causing esophageal damage, inflammation, or symptoms like heartburn and regurgitation.
• Benefits: Rapidly reduces acid exposure, healing erosions in 4-8 weeks and preventing complications like Barrett's esophagus, improving swallowing and sleep quality.

1. Peptic Ulcers (Gastric or Duodenal):

• Use: Manages active ulcers, especially those with bleeding, perforation, or Helicobacter pylori infection.
• Benefits: Accelerates ulcer healing (by 50-70% faster than antacids alone), reduces pain and bleeding risk, and eradicates H. pylori when combined with antibiotics.

1. Zollinger-Ellison Syndrome:

• Use: Controls hypersecretory states from gastrinomas leading to multiple ulcers and high acid output.
• Benefits: Suppresses acid production by up to 99%, alleviating severe symptoms and preventing recurrent ulcers or diarrhea.

1. Prevention of Stress Ulcers in Critical Illness:

• Use: Prophylaxis in ICU patients at risk (e.g., ventilated, trauma, burns) to prevent NSAID- or steroid-induced ulcers.
• Benefits: Lowers gastrointestinal bleeding risk by 50-70%, supporting recovery without interfering with nutrition or other therapies.

1. Upper GI Bleeding or Erosive Gastritis:

• Use: Stabilizes acute bleeding from ulcers or erosions unresponsive to oral therapy.
• Benefits: Promotes clot stabilization and mucosal repair, reducing hospitalization duration and transfusion needs.

1. Adjunct in H. pylori Eradication Therapy:

• Use: Part of triple/quadruple therapy with antibiotics for infected ulcers.
• Benefits: Enhances eradication rates to 85-90%, preventing relapse and reducing long-term cancer risk.

Dosage and Administration:

• Adults: Typically, 40 mg once daily by slow IV injection (over 2-15 minutes) or infusion (over 15-30 minutes), reconstituted in 10 ml solvent. For Zollinger-Ellison or severe cases, up to 80 mg twice daily. Duration: 3-10 days, then switch to oral.
• Children/Adolescents (≥40 kg): 20-40 mg daily, as prescribed; not recommended under 40 kg without specialist advice.
• Administered by healthcare professionals only; dilute if needed for infusion. Monitor for injection site reactions. Adjust in renal/hepatic impairment. Complete the course as directed to avoid rebound acidity.

Side Effects:

Common (usually mild and transient):

• Headache, dizziness, or diarrhea.
• Nausea, vomiting, abdominal pain, or flatulence.
• Injection site reactions (pain, swelling, redness).

Less common/rare:

• Dry mouth, insomnia, or rash.
• Serious: Low magnesium (symptoms: muscle spasms, irregular heartbeat—monitor levels), severe allergic reactions (swelling, anaphylaxis), or increased infection risk (e.g., C. difficile diarrhea). Long-term use may raise fracture or vitamin B12 deficiency risk.

Seek immediate medical help for severe symptoms; most resolve post-treatment.

Precautions and Warnings:

• Allergies: Avoid if hypersensitive to pantoprazole, other PPIs, or any component.
• Pregnancy/Breastfeeding: Category B—use only if benefits outweigh risks (limited human data; animal studies show no fetal harm). Passes into breast milk; prefer alternatives for newborns/preterm infants.
• Other Conditions: Inform your doctor of liver/kidney disease, low magnesium, osteoporosis, or lupus (may worsen). Elderly patients need monitoring for falls/fractures. Not for long-term use (>8 weeks) without reassessment.
• Drug Interactions: May reduce absorption of ketoconazole, methotrexate, or digoxin; increases warfarin effects (bleeding risk). Avoid with rilpivirine (HIV meds). No major alcohol interaction, but limit to avoid GI irritation.
• Regular blood tests for magnesium, liver/kidney function advised. Discontinue if rash or joint pain occurs.